Johnson & Johnson Vision will launch Tecnis Synergy Toric II IOL with the Tecnis Simplicity Delivery System, a continuous-range-of-vision IOL, at the upcoming virtual European Society of Cataract and Refractive Surgeons (ESCRS) 2020 Annual Meeting, October 2-4.
In addition, the company will present the first post-marketing clinical researching findings on Tecnis Synergy and the Tecnis Toric II platform, as well as additional clinical outcomes and field advancing studies. Johnson & Johnson Vision will also launch Catalys System cOS 6.0 software, which offers new features for astigmatism management workflow for surgeons using the Catalys Precision Laser System.
“We are very excited to launch Tecnis Synergy Toric II at ESCRS 2020 and to bring this important innovation to cataract patients with astigmatism,” Rajesh Rajpal, MD, Chief Medical Officer and Global Head of Clinical and Medical Affairs, Johnson & Johnson Vision, said in a company news release. “We are also pleased to present the first post-marketing clinical research studies on both Tecnis Synergy and the Tecnis Toric II platform. Surgeon feedback on the patient benefits of these technologies has been very strong.”
“At Johnson & Johnson Vision, we are always striving to improve the standard of care for cataract patients,” Erin McEachren, Regional Vice President, Europe, Middle East & Africa, Johnson & Johnson Surgical Vision, said in the news release. “We are excited to be unveiling virtually our new portfolio of products, from our latest toric IOL, the Tecnis Synergy Toric II, which offers our most advanced solution to cataract patients with astigmatism in a preloaded delivery system, to our latest software development, Catalys System cOS 6.0, that allows for better accuracy, speed and ease of use for a whole range of astigmatism procedures.”
“Despite the congress being virtual this year, we will be presenting a range of new data findings and hosting several educational events within our first J&J Vision Virtual Lighthouse, which will focus on fostering community collaboration and provide a virtual space for networking, knowledge sharing, and showcasing J&J’s innovative portfolio of products.”
First Post-Marketing Clinical Trial Data for Tecnis Synergy IOL and Tecnis Toric II Platform:
- Post-Market Evaluation of Surgeon Feedback on TECNIS Toric II Intraocular lens. D.Chang
- This prospective, multicenter, single-arm, open-label clinical study measured surgeon feedback from Tecnis Toric II 1-Piece IOL implantations in the U.S. Surgeons rated their confidence level in controlling IOL position following implantaion and satisfaction with overall clincial outcomes, rotational stability as well as overall clincial performance. Overall responses at 1 week showed that the majority of surgeons were extremely or quite confident in controlling lens position and rotational stability.
- Depth of Focus, Visual Outcomes, and Spectacle Independence of a New Diffractive Presbyopia-Correcting Intraocular Lens. A. Villarrubia
- This prospective, bilateral, multi-center clinical trial compared the performance of Tecnis Synergy IOL, with its continuous high-contrast vision from far through near, against a trifocal IOL (model TFNT00). In the trial, adults requiring cataract surgery or refractive lensectomy were randomized 2:1 to Tecnis Synergy IOL or the trifocal. Interim data from 83 subjects were available at three months of the 12-month study. More than 90 percent of patients receiving the Tecnis Synergy IOL reported that they did not wear glasses overall or for far, intermediate, or near distances, in contrast to patients with the trifocal IOL (less than 90 percent at each distance).
Additional Johnson & Johnson Vision Scientific Abstracts at ESCRS include:
- Humanistic and Economic Burden in Patients with Visually Significant Astigmatism and Cataracts. Domingo, Joy and Pastuck, Tawnya
- Clinical Investigation of a New Preloaded, Disposable Insertion System used during Cataract Surgery. Black, Daniel.
- Surgeon Acceptance and Safety of a New Ophthalmic Viscosurgical Device (OVD). Gavin, A.
- Effect of Pupil Size and Light Conditions in Monofocal Intraocular Lenses. Alarcon, A.
- Visual and Non-Visual Benefits of Violet Blocking IOLs. D.Chang
J&J Vision’s Activities at ESCRS at the J&J Virtual Lighthouse:
Throughout the meeting, the company will host a series of educational and interactive sessions aimed at sparking conversation and providing an opportunity to share, discuss and learn from leading experts in the field of ophthalmology. These include:
- EuroTimes Satellite Education Program – “Beyond Functional Vision – Turning IOL visual performance into real patient benefits” Webinar, 3rd October 2020, 13:00 – 14:00 h CET
- Chairperson: Filomena Ribeiro (PT) / Speakers: Prof. Filomena Ribeiro (PT), Prof. Tobias Röck (DE), Prof. Ulrich Schiefer (DE), Dr. Judith Ungewiss (DE), Dr. Francesco Carones (IT)
- EuroTimes Satellite Education Program – “Keys to success with today’s presbyopia and toric lens technologies” Webinar, 3rd October 2020
- Speakers: Filomena Ribeiro (PT), Prof. Ulrich Schiefer (GER), Dr. Francesco Carones (IT)